Qing Li Peptide
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Qing Li Peptide between 9 Jun 2025 and 11 Jun 2025. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).
Finnrick Rating™
Tentative Rating
Qing Li Peptide
Retatrutide
Tested 3 Samples
Last test 11 Jun 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qing Li Peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
11 Jun 2025
First
9 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 11 Jun 2025 | View | 20mg | 33.600mg | +68.0% | 99.81% | (no batch ID) | No Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 9 Jun 2025 | View | 10mg | 8.280mg | -17.2% | 99.62% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 9 Jun 2025 | View | 15mg | 17.300mg | +15.3% | 99.70% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |